Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at NPSF
Friday, May 22, 2009
WASHINGTON, DC, May 22, 2009 – The Partnership for Clear Health Communication at the National Patient Safety Foundation (NPSF) today announced the recipients of the prestigious Pfizer Health Literacy in Advancing Patient Safety Award. Honored for their innovative and influential efforts in the Health Literacy field were Dr. Michael Wolf, Director of the Center for Communication in Healthcare at Northwestern University’s Feinberg School of Medicine, and Dr. Rima Rudd, Senior Lecturer on Society, Human Development, and Health at the Harvard School of Public Health.
This award, established in 2008 and made possible through a generous grant from Pfizer, Inc., was established to recognize the critical importance of health literacy to advancing patient safety and quality of care, and to acknowledge those on the forefront of this essential work.
Dr. Wolf’s impressive efforts as Assistant Professor of Medicine and Learning Sciences and Co-Founder of the Health Literacy and Learning program at Northwestern has helped to bring health literacy and patient safety to the forefront of research and policy, most particularly in the area of medication safety. “Driven by a fundamental desire to keep patients safe and improve the quality of care, Michael Wolf brings vision, innovation, and real-world solutions to the field of health literacy,” said Diane Pinakiewicz, President of the National Patient Safety Foundation.
He is recognized throughout healthcare as a leader in seeking improvement in the quality of consumer medication information among low literacy patient populations and is currently leading the way with colleagues in setting universal standards in how medication instructions are written.
Dr. Rudd’s work has clearly demonstrated that literacy is a major factor contributing to disparities in health status, access to care, and quality of care for many members of our society, and stresses the critical need for public health and medical professionals to respond to this important issue. “She is a true pioneer and leader in the burgeoning field of health literacy,” said Ms. Pinakiewicz.
Dr. Rudd’s models for assessing the literacy environment of health centers and hospitals are being adopted here in the US and abroad. Her collective body of work is evident of a deep and abiding commitment to providing low literacy populations with the knowledge and skills needed to better navigate the health care system.
“The thought-leadership and research efforts of this year’s Health Literacy Award recipients have advanced the field in ways that have significant and meaningful impact,” said Pinakiewicz, “and we are honored to recognize their many achievements.”
The Pfizer Health Literacy in Advancing Patient Safety Award was conferred to Dr. Wolf and Dr. Rudd at the 2009 NPSF Patient Safety Congress in Washington, DC, and recipients shared a $15,000 one-time grant from Pfizer in recognition of their work.
About The Partnership for Clear Health Communication at the National Patient Safety Foundation
The Partnership for Clear Health Communication (PCHC) at the National Patient Safety Foundation is a national, non-profit 501(c)(3) coalition that serves as an information source regarding the scope and impact of health literacy in the U.S., as well as what providers and patients can do to improve health communication in every provider-patient interaction.
About the National Patient Safety Foundation
The National Patient Safety Foundation® is an independent not-for-profit 501(c)(3) organization that has been diligently pursuing one mission since its founding in 1997 – to improve the safety of the healthcare system for the patients and families it serves. NPSF is unwavering in its determined and committed focus on uniting disciplines and organizations across the continuum of care, championing a collaborative, inclusive, multi-stakeholder approach.
Founded in 1849, Pfizer is the world’s premier biopharmaceutical company, taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, more than 80,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and reduce the human and economic burden of disease worldwide.